Solid Biosciences (SLDB) Insider Trading & Ownership $4.37 +0.11 (+2.58%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$4.36 -0.01 (-0.34%) As of 03/27/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Solid Biosciences (NASDAQ:SLDB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.63%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$18,369.40Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$161,072.73 Get SLDB Insider Trade Alerts Want to know when executives and insiders are buying or selling Solid Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SLDB Insider Buying and Selling by Quarter Remove Ads Solid Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2025Clare KahnDirectorBuy1,860$5.34$9,932.40 1/28/2025Ilan GanotDirectorSell144$3.11$447.84 1/10/2025Kevin TanCFOSell4,073$3.89$15,843.97 1/6/2025Ilan GanotDirectorSell1,056$4.31$4,551.36 12/3/2024Alexander CumboCEOSell11,114$5.60$62,238.40 12/3/2024David T HowtonCOOSell5,072$5.60$28,403.20 12/3/2024Jessie HanrahanInsiderSell4,610$5.60$25,816.00 10/21/2024Gabriel BrooksInsiderSell2,923$6.50$18,999.50 6/7/2024Clare KahnDirectorBuy1,100$7.67$8,437.00 5/2/2024Ilan GanotDirectorSell462$10.33$4,772.46 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) SLDB Insider Trading Activity - Frequently Asked Questions Who is on Solid Biosciences's Insider Roster? The list of insiders at Solid Biosciences includes Alexander Cumbo, Carl Ashley Morris, Clare Kahn, David T Howton, Gabriel Brooks, Ilan Ganot, Jessie Hanrahan, Kevin Tan, Paul Herzich, and Perceptive Advisors Llc. Learn more on insiders at SLDB. What percentage of Solid Biosciences stock is owned by insiders? 13.63% of Solid Biosciences stock is owned by insiders. Learn more on SLDB's insider holdings. Which Solid Biosciences insiders have been buying company stock? The following insiders have purchased SLDB shares in the last 24 months: Clare Kahn ($18,369.40), and Perceptive Advisors Llc ($18,861,242.89). How much insider buying is happening at Solid Biosciences? Insiders have purchased a total of 3,413,673 SLDB shares in the last 24 months for a total of $18,879,612.29 bought. Which Solid Biosciences insiders have been selling company stock? The following insiders have sold SLDB shares in the last 24 months: Alexander Cumbo ($94,805.29), David T Howton ($43,323.46), Gabriel Brooks ($18,999.50), Ilan Ganot ($19,296.82), Jessie Hanrahan ($39,379.62), Kevin Tan ($48,110.97), and Paul Herzich ($8,221.36). How much insider selling is happening at Solid Biosciences? Insiders have sold a total of 60,128 Solid Biosciences shares in the last 24 months for a total of $272,137.02 sold. Solid Biosciences Key ExecutivesMr. Ian F. Smith A.C.A. (Age 58)C.P.A., Executive Chair Compensation: $75kMr. Alexander G. Cumbo (Age 53)President, CEO & Director Compensation: $918.55k1 recent tradesMr. Ilan Ganot (Age 50)Co-founder, Strategic Advisor to the CEO & Director Compensation: $847.87k2 recent tradesMr. Kevin Tan C.F.A. (Age 46)CFO & Treasurer Compensation: $607.18kMr. David Tyronne Howton Jr. (Age 52)J.D., COO, General Counsel & Secretary Compensation: $648.88kMs. Annie GanotCo-Founder & Head of Patient AdvocacyMr. Paul Herzich (Age 46)Chief Technology Officer Dr. Jennifer Marlowe Ph.D. (Age 47)Chief Scientific Officer Ms. Allison Bogosian J.D.Senior Vice President of Human ResourcesDr. Jessie Hanrahan Ph.D. (Age 48)Chief Regulatory Officer More Insider Trading Tools from MarketBeat Related Companies ANI Pharmaceuticals Insider Buying Dyne Therapeutics Insider Buying Amphastar Pharmaceuticals Insider Buying 89bio Insider Buying Adaptive Biotechnologies Insider Buying ARS Pharmaceuticals Insider Buying Ardelyx Insider Buying Ocular Therapeutix Insider Buying Structure Therapeutics Insider Buying Iovance Biotherapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:SLDB) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLDB Stock Free SLDB Stock Alerts